Reuters

Tearlab corporation provides update on U.S. regulatory strategy for Tearlab Discovery™ System

* Tearlab Corp says it has elected to pursue initial U.S. FDA clearance of a test card measuring a single inflammatory biomarker, MMP-9, in combination with co's osmolarity test * Tearlab - ‍ elected ...
Healio

510(k) application submitted to FDA for TearLab Discovery platform

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio TearLab has submitted a 510(k) ...
Seeking Alpha

TearLab provides update on 510(k) filing for FDA clearance of TearLab Discovery Platform

TearLab Corporation (OTC:TEAR) has received written feedback from the FDA on the requirements for 510(k) clearance of its TearLab Discovery Platform and test card measuring the inflammatory biomarker, ...
Business Insider

TearLab Update on 510(k) for U.S. FDA Clearance of Discovery™ MMP-9 Test

SAN DIEGO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has determined that the ...
Business Insider

TearLab Announces European Regulatory Clearance for Next-Generation TearLab Discovery™ System

SAN DIEGO, July 21, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (the “Company”) today announced that the commercial version of its next-generation in-vitro diagnostics testing ...
NBC News

TearLab Teams With COLA to Help Accelerate Osmolarity Test's Migration to the Point-of-Care

SAN DIEGO, Jan. 11, 2011 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") and COLA, a private, non-profit clinical laboratory education, consultation and ...